Phage therapy program
National Jewish Health / POSTSTAMP
| Status | Intake unconfirmed |
|---|---|
| Type | Center |
| Location | Denver, Colorado; United States |
| Entry review | 2026-10-04 |
Access and enquiries
| How to enquire | POSTSTAMP (NCT06262282) is enrolling by invitation. Its protocol screens people with cystic fibrosis and persistent NTM infection for a matching phage and offers matched participants assistance seeking individual FDA compassionate-use authorization. Study participation does not guarantee phage treatment; no general open phage intake route was verified. |
|---|---|
| Areas of work | Invitation-only observational cohort for persistent NTM infection after at least 12 months of guideline-based therapy in people with cystic fibrosis; usual antibiotics continue. Earlier institutional evidence describes a 2022 Mycobacterium abscessus case. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- The registry protocol was last updated May 21, 2025; a fresh retrieval is not a fresh recruitment-status update.
- Listed facilities without local recruitment status are not confirmed recruiting treatment sites.
- The older institutional case report remains excerpt-only evidence; the current pathway wording is supported separately by the full registry protocol.
Related studies(1)
POSTSTAMP
Invitation only
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
- POSTSTAMP: NCT06262282 registry protocol
- Researchers Use Virus to Fight Bacterial Infection, Clearing Way for Life-Saving Lung Transplant
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | national-jewish |
|---|